Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Atlanta’s leading healthcare centers are recruiting participants for studies focused on developing innovative treatments for conditions such as cancer, depression, high blood pressure, and kidney disease. Whether you’re searching for paid clinical research opportunities as a healthy volunteer or trials for specific conditions, Atlanta provides a wide range of research options to meet your needs.
Filter
2
Filter results
Results: 1,670
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for
Multiple Sclerosis
Location: Atlanta GA, Smyrna GA, Homewood AL, Cullman AL,
Sponsor: Sanofi
Sex: All
Age: 18 - 60
Code: NCT07325292
Phase 3, Recruiting
Efficacy of EXPAREL vs. Bupivacaine
for
Total Ankle Arthroplasty, Postsurgical Analgesia
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT07212114
Phase 3, Recruiting
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Decatur GA, Marietta GA, Columbia SC, Fayetteville NC,
Sponsor: Eccogene
Sex: All
Age: 18 - 70+
Code: NCT07288138
Phase 2, Recruiting
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
for
Schizophrenia
Location: Decatur GA, St Louis MO, Bentonville AR, Miami FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07467993
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19
for
COVID-19
Location: Decatur GA, Atlanta GA, Cincinnati OH, New Orleans LA,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07861542
Phase 4, Recruiting
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Location: Atlanta GA, Knoxville TN, Louisville KY, Ridgeland MS,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06649110
Phase 1, Phase 2, Recruiting
Cardiology Biobank Registry
for
Cardiovascular Disease
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 20+
Code: NCT00378924
Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for
Focal Segmental Glomerulosclerosis,
Location: Atlanta GA, Birmingham AL, Chapel Hill NC, Tampa FL,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT06500702
Phase 2, Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Atlanta GA, Charlottesville VA, Chicago IL,
Location: Decatur GA, Chapel Hill NC, New Orleans LA, Chicago IL,
Sponsor: Lipocine Inc.
Sex: Female
Age: 15 - 45
Code: NCT07822321
Phase 3, Recruiting
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
for
Healthy Volunteers, Influenza
Location: Decatur GA, Knoxville TN, North Charleston SC,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07779408
Phase 1, Phase 2, Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
for
Solid Malignancies, Hematologic Malignancies
Location: Atlanta GA, Nashville TN, Charlotte NC, Louisville KY,
Sponsor: Immunome, Inc.
Sex: All
Age: 18+
Code: NCT06823167
Phase 1, Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors